Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Nihon Kohden Corporation ( (JP:6849) ) has provided an update.
Nihon Kohden Corporation announced its decision to acquire additional shares of its subsidiary, NeuroAdvanced Corp. (NAC), making it a wholly owned subsidiary. This acquisition follows a put option exercised by NeuroNewCo, LP, allowing Nihon Kohden to purchase the remaining 28.6% shares of NAC. The acquisition, scheduled for completion on July 9, 2025, will have a minor impact on the company’s consolidated results for FY2025, as NAC and its subsidiary Ad-Tech are already consolidated entities.
The most recent analyst rating on (JP:6849) stock is a Sell with a Yen1500.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.
More about Nihon Kohden Corporation
Nihon Kohden Corporation operates in the medical equipment industry, focusing on the development and manufacturing of innovative medical devices and technologies. The company is known for its products in patient monitoring, medical electronics, and healthcare information technology, catering to a global market.
Average Trading Volume: 689,314
Technical Sentiment Signal: Sell
Current Market Cap: Yen284.9B
See more data about 6849 stock on TipRanks’ Stock Analysis page.